Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of febuxostat, once daily (QD),
compared to allopurinol or placebo in patients with excessive amounts of uric acid in their
urine and who have recently had kidney stones.